Coronavirus
-
A pill to treat Covid-19? The U.S. is betting on it
If all goes well, some of those first pills could be ready by the end of the year
-
What America's dramatic Covid-19 turnaround can teach India
The crisis response of the US shows that evidence-based leadership that respects data, scientists and experts, funds science and and coordinates its crisis response can dramatically turn around the fate of a country. India needs a course correction too
-
As vaccines turn pandemic's tide, US and Europe diverge on path forward
The divergent strategies of European nations and the United States also reflect broader differences in how Western governments are thinking about their responsibility to unvaccinated people
-
India's pharma companies are readying 900 million doses of Sputnik V. Can it pull the country out of its Covid-19 mess?
Amid concerns surrounding Sputnik V and the launch of a single-dose vaccine, Indian companies, including Hetero, Stelis, Biopharma and Gland Pharma are on track to make millions of doses of the Russian vaccine in a bid to alleviate the country's supply constraints
-
Just how big could India's true Covid-19 toll be?
The true death toll could range from roughly double the official figures to potentially catastrophic levels of unacknowledged deaths of well over 1 million or even higher
-
Pakistan's private vaccine sales highlight the rich-poor divide
Critics say the decision will deepen the divisions within the country, where a large section of the society lives under the poverty line
-
As India stumbles, one state charts its own Covid-19 course
Though supplies have tightened, Kerala's hospitals enjoy access to oxygen, with officials having expanded production months ago while coordination centres, called war rooms, direct patients and resources
-
Will made-in-India Sputnik V be the country's salvation?
As India struggles with vaccine shortages and a laggard inoculation programme, a clutch of local manufacturers, including Hetero Group of Companies, Gland Pharma and Stelis Biopharma has set out to produce the contentious Sputnik V vaccine in a bid to alleviate supply constraints. Subscribe to Forbes India for early access
-
For India's medical workers, danger and 'heartbreaking decisions'
The Indian Medical Association said more than 1,000 doctors have died from Covid-19 since the pandemic hit last year, with a quarter of those dying since the beginning of April alone
-
Covid-19 Vaccine FAQs, Children Edition: We answer your frequently asked questions about coronavirus spread amongst kids
The second wave of Covid-19 in India has brought devastation of unimagined proportions and it is also affecting children. In part three of our Vaccine FAQs series, Dr Puneet Anand—Associate Consultant (Paediatrics and Neonatology), Fortis Hospital, Himachal Pradesh—answers queries posed by concerned parents and caregivers. From 'Do kids face a high risk of catching Covid-19?' to 'What precautions do parents need to take to avoid MIS-C in kids?'
-
Wealth disparity, legal hurdles and supply hamper effort to vaccinate world
Only 0.3% of the vaccine doses administered globally have been given in the 29 poorest countries, home to about 9% of the world's population